Prevalence of Group B Streptococcus in Vagina and Rectum of Pregnant Women of Islamic &amp; Non-Islamic Countries: A Systematic Review and Meta-Analysis

Abbasalizadeh, Fatemeh; Pourasghary, Sajjad; Shirizadeh, Maryam; Mousavi, Seyed Reza; Ghojazadeh, Morteza; Hoseinifard, Hossein; Salehnia, Fatemeh; Nikniaz, Leila

doi:10.18502/ijph.v50i5.6106

Cited by 4 publications

(5 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In contrast, as shown in Table 3, the pooled prevalence is much lower in Asia. A prevalence 11.1% in South East Asia, 65 12.9% in Asia 67 and 10% in China 66 . We found a prevalence of 11.8% for Asia, which included countries from East, South and West Asia concurring with findings from previous reviews.…”

Section: Discussionsupporting

confidence: 90%

“…We found a prevalence of 11.8% for Asia, which included countries from East, South and West Asia concurring with findings from previous reviews. Data from the Americas and Europe demonstrate a pooled prevalence that is intermediate; in the Americas, it ranged from 18.6% 67 to 19.7% 65 ; in Europe, from 16.4% 67 to 19.0% 65 . Results from our analysis show a similar trend; the pooled prevalence is 22.6% for the Americas and 19.7% for Europe.…”

Section: Discussionsupporting

confidence: 61%

“…In terms of regional distribution, a relatively high pooled prevalence was reported from African countries ranging from 19% 67 to 20.4% 65 and 21.8% 68 . In the present review, we noted a pooled prevalence of 23.7% for the African region, the highest yet reported.…”

Section: Discussionsupporting

confidence: 47%

See 2 more Smart Citations

Maternal and neonatal group B streptococcus colonisation: A systematic review and the meta‐analysis of matched‐pair studies

Lee,

Yap,

Murdan

et al. 2024

Acta Paediatrica

View full text Add to dashboard Cite

AimTo determine the prevalence of group B Streptococcus (GBS) carriage among parturient women and neonates, and the relative risk of vertical transmission, the relative risk of early and late‐onset GBS and the pooled incidence of early‐late‐onset GBS infection.MethodsA systematic search of relevant cohort studies from three electronic databases to identify all relevant studies published up to 7 November 2022. The review was conducted in accordance with PRISMA guidelines. Estimates were pooled using random‐effects meta‐analyses.ResultsA total of 54 articles with 355 787 matched pairs of parturient women and neonates from 30 countries were included in the analysis. The pooled prevalence of GBS colonisation was 17.1% among the pregnant women and 1.0% among neonates. The pooled prevalence of vertical transmission of GBS was 4.5% and the pooled relative risk of GBS colonisation of neonates born to mothers with GBS was 9.9.ConclusionWe support the implementation of targeted intrapartum antibiotic prophylaxis for all women who are positive for GBS as well as women with risks factors for early onset GBS in their infants regardless of their GBS colonisation status.

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Discussionsupporting

confidence: 61%

See 1 more Smart Citation

Maternal and neonatal group B streptococcus colonisation: A systematic review and the meta‐analysis of matched‐pair studies

Lee,

Yap,

Murdan

et al. 2024

Acta Paediatrica

View full text Add to dashboard Cite

show abstract

“…The prevalence of maternal GBS colonization in studies that reported samples from pregnant women before 35 weeks of pregnancy was 17% (95% CI, 15–18%), then 15% (95% CI, 13–16%) in those sampled after 35 weeks and 14% (95% CI, 13–16%) at the moment of delivery [ 2 ]. Another systematic review conducted by Abbasalizadeh F. et al included 245 full texts that reported the prevalence of GBS colonization in pregnant women from all the studied countries was 15.5% (95% CI, 14.2–17%) [ 36 ]. Similar results were obtained in the present study, where the prevalence of colonized pregnant women included in the study was 17.3%.…”

Section: Discussionmentioning

confidence: 99%

Antimicrobial Resistance Profile of Group B Streptococci Colonization in a Sample Population of Pregnant Women from Romania

Petca,

Șandru,

Negoiță

et al. 2024

Microorganisms

View full text Add to dashboard Cite

Group B Streptococcus (GBS) represents one of the leading causes of life-threatening invasive disease in pregnant women and neonates. Rates of GBS colonization vary by region, but studies on maternal GBS status are limited in Romania. This study aims to identify the prevalence of colonization with GBS and whether the obstetrical characteristics are statistically associated with the study group’s antimicrobial susceptibility patterns of tested GBS strains. This observational study was conducted between 1 May and 31 December 2021 at The Department of Obstetrics and Gynecology at Elias University Emergency Hospital (EUEH) in Bucharest, Romania. A total of 152 samples were positive for GBS and included in the study according to the inclusion criteria. As a result, the prevalence of colonized patients with GBS was 17.3%. GBS isolated in this population had the highest resistance to erythromycin (n = 38; 25%), followed by clindamycin (n = 36; 23.7%). Regarding the susceptibility patterns of tested strains to penicillin, the 152 susceptible strains had MIC breakpoints less than 0.06 μg/μL. The susceptibility patterns of tested strains to linezolid indicated three resistant strains with low levels of resistance (MICs ranging between 2 and 3 μg/μL). Multidrug resistance (at least three antibiotic classes) was not observed. In conclusion, although GBS naturally displays sensitivity to penicillin, the exact bacterial susceptibility testing should be performed in all cases where second-line therapy is taken into consideration for treatment. We acknowledge the need for future actions to limit multidrug-resistant bacteria.

show abstract

“… 32 The pooled estimated prevalence of Group B Streptococcus in the vagina and rectum of pregnant women in Islamic and non-Islamic countries was 15% and 14%, respectively, according to a meta-analysis and systemic review. 33 Standards and laboratory diagnostic methods, differences in study location, differences in respondents’ residence, differences in previous obstetric history, bacteriological method for organism detection, statistical differences in the study population, laboratory staff skill, and health and medical policies of countries and geographic regions could all contribute to the disparity.…”

Section: Discussionmentioning

confidence: 99%

Prevalence and antimicrobial susceptibility of group B streptococci among pregnant women in Ethiopia: A systemic review and meta-analysis study

2022

View full text Add to dashboard Cite

Objective: Maternal colonization or infection with drug-resistant Group B streptococcus is a serious disease that affects mother, fetus, and infant. The knowledge of maternal colonization and antimicrobial susceptibility test is substantially needed for a nation to formulate a policy or change the already existing one to reduce maternal, fetus, and infant mortality. As a result, the goal of this review was to determine the pooled prevalence Group B streptococcus colonization and antimicrobial susceptibility among Ethiopian pregnant women. Methods: Literature searches were carried out in the electronic biomedical databases and indexing services such as PubMed/MEDLINE, Scopus, Science Direct, Web of Science, and Google Scholar. Original records of research articles, available online from 2014 to December 2020, addressing prevalence and antimicrobial-resistance pattern of Group B streptococcus in pregnant women were identified and screened. Endnote citation manager software version X9 for windows was utilized to collect and organize search outcomes and for removal of duplicate articles. The relevant data were extracted from included studies using a format prepared in Microsoft Excel and exported to STATA 14.0 software for the outcome measures analyses and subgrouping. The I2 index was used to measure heterogeneity between studies and median, and interquartile (25%, 75%) was used to assess antimicrobial susceptibility rate. Results and conclusion: Sixteen original articles were found in both qualitative and quantitative analyses. Group B streptococcus colonization was recorded in 979 of the 5743 pregnant women, resulting in a 16% overall frequency (95% confidence interval: 13%−20%). The estimated prevalence varied significantly between studies with significant heterogeneity (χ2 = 154.31, p = 0.001, I2 = 90.28). Ampicillin (97.8%; interquartile range = 89.5%−100%), penicillin G (95.5%; interquartile range = 89.5%−100%), and vancomycin (100%; interquartile range = 89.5%−100%) susceptibility were all high in Group B streptococcus, whereas tetracycline (29%; interquartile range = 89.5%−100%) susceptibility was low. Group B streptococcus colonization rates in Ethiopian women during pregnancy were virtually similar to those in many underdeveloped countries, and Group B streptococcus isolates were highly sensitive to ampicillin, penicillin G, and vancomycin.

show abstract

Prevalence of Group B Streptococcus in Vagina and Rectum of Pregnant Women of Islamic & Non-Islamic Countries: A Systematic Review and Meta-Analysis

Cited by 4 publications

References 11 publications

Maternal and neonatal group B streptococcus colonisation: A systematic review and the meta‐analysis of matched‐pair studies

Maternal and neonatal group B streptococcus colonisation: A systematic review and the meta‐analysis of matched‐pair studies

Antimicrobial Resistance Profile of Group B Streptococci Colonization in a Sample Population of Pregnant Women from Romania

Prevalence and antimicrobial susceptibility of group B streptococci among pregnant women in Ethiopia: A systemic review and meta-analysis study

Contact Info

Product

Resources

About